目前阿茲海默氏症發病率持續上升，又缺乏有效治療方法的現況已造成全球醫療嚴重的挑戰。近期有研究指出硫化氫對許多神經退化性疾病如阿茲海默氏症具有抗氧化、抗細胞凋亡，以及抗發炎的效果。然而，硫化氫、類澱粉蛋白，以及tau蛋白之間的關聯性尚未闡明。在此研究中，我們將以oligomeric Aβ42處理的海馬迴初級神經元培養系統與給予壓力的阿茲海默氏症基因轉殖鼠探討硫化氫對於阿茲海默氏症的作用效果與機轉。首先，在建立海馬迴初級神經元培養系統中確認培養到第9天時，海馬迴神經元之樹突開始延展及分支;另外也發現2 μM AraC能抑制星型膠細胞之生長且對神經元造成之傷害性較小。在確認了海馬迴初級神經元培養系統之條件後，我們接著進行1 μM oligomeric Aβ42對細胞處理0，0.5，1，6及12小時後之影響，發現1 μM oligomeric Aβ42培養1小時後會造成細胞存活率下降、LDH釋放量增加、成熟神經元數目減少、神經突數目與長度減少及突觸密度下降等傷害，所以以1μM oligomeric Aβ42培養1小時為一進行藥物評估之適合條件。另外，不同劑量的硫化氫鈉（硫化氫供應物）與oligomeric Aβ42以前處理、共同處理及後處理三種方式加入海馬迴初級神經元培養系統內，我們發現50 μM硫化氫鈉前處理或共同處理oligomeric Aβ42及10 μM硫化氫鈉後處理可以保護海馬迴初級神經元培養的神經細胞型態及突觸密度。在動物實驗上發現電刺激所產生的壓力對於6個月大的阿茲海默氏症基因轉殖鼠僅造成有限之傷害。因此，此種電刺激之強度及給予方式對於6個月大的阿茲海默氏症基因轉殖鼠可能不足以產生嚴重之壓力。另外，硫化氫鈉之給予可以避免認知功能之退化可能是經由PERK/eIF2α途徑所產生的抗氧化與抗發炎反應於電刺激的阿茲海默氏症基因轉殖鼠。。因此，硫化氫對於阿茲海默氏症或許是一個具有潛力的治療策略之選擇。

The worldwide incidence of Alzheimer's disease (AD) is increasing and creating an unsustainable healthcare challenge due to a lack of effective treatment options. Recent evidence shows that H2S could exert antioxidant, anti-apoptotic, and anti-inflammatory effects against neurodegenerative disease such as AD. However, the correlation among H2S, Aβ and tau protein in AD are not been fully elucidated. In this study, the effects and molecular mechanisms of H2S in AD were investigated in hippocampal primary neuronal culture and APP/PS1/Tau triple transgenic (3×Tg-AD) mice with inescapable foot-shock stress. At first, we established the hippocampal primary neuronal culture as an in vitro platform for a primary study. The neuronal processes were extended and branched on 9 days in vitro (DIV). In addition, the medium with 2 μM cytosine arabinoside (AraC) inhibited the population of astrocyte associated with limited neuronal damage. We then evaluated the effects of 1 μM oligomeric Aβ42 on hippocampal primary neurons with cultivating timing from 0.5 to 12 hr. We found that 1 hr treatment induced total cell loss and lactate dehydrogenase (LDH) released, and mature neuronal number, neuritic length, processes, branches, and synaptic density decreased. Therefore, treatment of oligomeric Aβ42 for 1 hr is an optimized timing for evaluation of drug treatment. Different concentrations of NaHS (an H2S donor) were applied to oligomeric Aβ42-treated hippocampal primary neuronal culture in pre-, co-, or post-treatment manners. We further found that NaHS pre-/co-treatment (50 μM) and post-treatment (10 μM) could effectively attenuate oligomeric Aβ42-induced toxicity. We then evaluate the in vivo effect of NaHS on the 3×Tg-AD mice associated with inescapable foot-shock stress. The 3×Tg-AD mice (6 month-old) with stress were administrated with either NaHS or vehicle, and subjected to a series of behavioral evaluation (light-dark transition test, open field test, elevated plus maze, and Morris water maze). We found that inescapable foot-shock stress only induced limited impact in 3×Tg-AD mice. However, the administration of NaHS prevented the cognitive decline associated with anti-inflammation and anti-oxidation via PERK/eIF2α pathway in 3×Tg-AD mice with mild stress. Therefore, H2S is a potential therapeutic strategy to prevent the cognitive dysfunction for AD.

Agostinho P, Oliveira CR (2003) Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides. Eur J Neurosci 17:1189-1196.
Ahlemeyer B, Baumgart-Vogt E (2005) Optimized protocols for the simultaneous preparation of primary neuronal cultures of the neocortex, hippocampus and cerebellum from individual newborn (P0.5) C57Bl/6J mice. J Neurosci Methods 149:110-120.
Aisen PS (2005) The development of anti-amyloid therapy for Alzheimer's disease : from secretase modulators to polymerisation inhibitors. CNS Drugs 19:989-996.
Ambree O, Leimer U, Herring A, Gortz N, Sachser N, Heneka MT, Paulus W, Keyvani K (2006) Reduction of amyloid angiopathy and Abeta plaque burden after enriched housing in TgCRND8 mice: involvement of multiple pathways. The American journal of pathology 169:544-552.
Aplin AE, Jacobsen JS, Anderton BH, Gallo JM (1997) Effect of increased glycogen synthase kinase-3 activity upon the maturation of the amyloid precursor protein in transfected cells. Neuroreport 8:639-643.
Atri A, Shaughnessy LW, Locascio JJ, Growdon JH (2008) Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer disease and associated disorders 22:209-221.
Auld DS, Kornecook TJ, Bastianetto S, Quirion R (2002) Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Progress in neurobiology 68:209-245.
Babic T (1999) The cholinergic hypothesis of Alzheimer's disease: a review of progress. Journal of neurology, neurosurgery, and psychiatry 67:558.
Baker KB, Kim JJ (2002) Effects of stress and hippocampal NMDA receptor antagonism on recognition memory in rats. Learn Mem 9:58-65.
Banker GA, Cowan WM (1977) Rat hippocampal neurons in dispersed cell culture. Brain research 126:397-342.
Barbero-Camps E, Fernandez A, Baulies A, Martinez L, Fernandez-Checa JC, Colell A (2014) Endoplasmic Reticulum Stress Mediates Amyloid beta Neurotoxicity via Mitochondrial Cholesterol Trafficking. Am J Pathol.
Castellani RJ, Perry G (2012) Pathogenesis and Disease-modifying Therapy in Alzheimer's Disease: The Flat Line of Progress. Arch Med Res.
Castellani RJ, Smith MA (2011) Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail'. J Pathol 224:147-152.
Chang JY, Brown S (1996) Cytosine arabinoside differentially alters survival and neurite outgrowth of neuronal PC12 cells. Biochem Biophys Res Commun 218:753-758.
Costall B, Jones BJ, Kelly ME, Naylor RJ, Tomkins DM (1989) Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32:777-785.
Costanza A, Bouras C, Kovari E, Giannakopoulos P (2012) [Alzheimer disease: from pathogenetic issues to clinical perspectives]. Rev Med Suisse 8:1770-1772, 1774.
Cui Z, Feng R, Jacobs S, Duan Y, Wang H, Cao X, Tsien JZ (2013) Increased NR2A:NR2B ratio compresses long-term depression range and constrains long-term memory. Scientific reports 3:1036.
Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403.
Davis KE, Easton A, Eacott MJ, Gigg J (2013) Episodic-like memory for what-where-which occasion is selectively impaired in the 3xTgAD mouse model of Alzheimer's disease. J Alzheimers Dis 33:681-698.
Devi L, Alldred MJ, Ginsberg SD, Ohno M (2010) Sex- and brain region-specific acceleration of beta-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease. Molecular brain 3:34.
Fan LY, Chiu MJ (2014) Combotherapy and current concepts as well as future strategies for the treatment of Alzheimer's disease. Neuropsychiatric disease and treatment 10:439-451.
Fath T, Eidenmuller J, Brandt R (2002) Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience 22:9733-9741.
Feng Y, Wang X (2012) Antioxidant therapies for Alzheimer's disease. Oxidative medicine and cellular longevity 2012:472932.
Flight MH (2013) Neurodegenerative diseases: New kinase targets for Alzheimer's disease. Nature reviews Drug discovery 12:739.
Foster KA, McLaughlin N, Edbauer D, Phillips M, Bolton A, Constantine-Paton M, Sheng M (2010) Distinct roles of NR2A and NR2B cytoplasmic tails in long-term potentiation. The Journal of neuroscience : the official journal of the Society for Neuroscience 30:2676-2685.
Gasparini L, Dityatev A (2008) Beta-amyloid and glutamate receptors. Experimental neurology 212:1-4.
Giese KP (2009) GSK-3: a key player in neurodegeneration and memory. IUBMB Life 61:516-521.
Giuliani D, Ottani A, Zaffe D, Galantucci M, Strinati F, Lodi R, Guarini S (2013) Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms. Neurobiology of learning and memory 104C:82-91.
Goate A, Hardy J (2012) Twenty years of Alzheimer's disease-causing mutations. Journal of neurochemistry 120 Suppl 1:3-8.
Griffin WS, Nicoll JA, Grimaldi LM, Sheng JG, Mrak RE (2000) The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk. Experimental gerontology 35:481-487.
Grigoryan G, Biella G, Albani D, Forloni G, Segal M (2014) Stress impairs synaptic plasticity in triple-transgenic Alzheimer's disease mice: rescue by ryanodine. Neuro-degenerative diseases 13:135-138.
Hanger DP, Betts JC, Loviny TL, Blackstock WP, Anderton BH (1998) New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. Journal of neurochemistry 71:2465-2476.
Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE (2008) Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Clinical interventions in aging 3:211-225.
Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nature reviews Neuroscience 11:682-696.
Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D, Jardanhazi-Kurutz D, Walter J, Kirchhoff F, Hanisch UK, Kummer MP (2010) Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proceedings of the National Academy of Sciences of the United States of America 107:6058-6063.
Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, Scheper W (2009) The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. The American journal of pathology 174:1241-1251.
Huang HJ, Liang KC, Chang YY, Ke HC, Lin JY, Hsieh-Li HM (2010) The interaction between acute oligomer Abeta(1-40) and stress severely impaired spatial learning and memory. Neurobiology of learning and memory 93:8-18.
Hureau C, Faller P (2009) Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease. Biochimie 91:1212-1217.
Johnson GV, Hartigan JA (1999) Tau protein in normal and Alzheimer's disease brain: an update. Journal of Alzheimer's disease : JAD 1:329-351.
Jope RS, Johnson GV (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29:95-102.
Kaech S, Banker G (2006) Culturing hippocampal neurons. Nature protocols 1:2406-2415.
Kajimura M, Fukuda R, Bateman RM, Yamamoto T, Suematsu M (2010) Interactions of multiple gas-transducing systems: hallmarks and uncertainties of CO, NO, and H2S gas biology. Antioxid Redox Signal 13:157-192.
Kar S, Slowikowski SP, Westaway D, Mount HT (2004) Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. Journal of psychiatry & neuroscience : JPN 29:427-441.
Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nature reviews Drug discovery 10:698-712.
Kart-Teke E, De Souza Silva MA, Huston JP, Dere E (2006) Wistar rats show episodic-like memory for unique experiences. Neurobiology of learning and memory 85:173-182.
Kasparek MS, Linden DR, Kreis ME, Sarr MG (2008) Gasotransmitters in the gastrointestinal tract. Surgery 143:455-459.
Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486-489.
Kimura H (2000) Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochemical and biophysical research communications 267:129-133.
Kirschenbaum F, Hsu SC, Cordell B, McCarthy JV (2001) Glycogen synthase kinase-3beta regulates presenilin 1 C-terminal fragment levels. The Journal of biological chemistry 276:30701-30707.
Kopp C, Longordo F, Luthi A (2007) Experience-dependent changes in NMDA receptor composition at mature central synapses. Neuropharmacology 53:1-9.
Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796-807.
Lee DC, Rizer J, Hunt JB, Selenica ML, Gordon MN, Morgan D (2012) Experimental manipulations of microglia in mouse models of Alzheimer's pathology. Activation reduces amyloid but hastens tau pathology. Neuropathol Appl Neurobiol.
Lefer DJ (2007) A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide. Proceedings of the National Academy of Sciences of the United States of America 104:17907-17908.
Li S, Jin M, Koeglsperger T, Shepardson NE, Shankar GM, Selkoe DJ (2011) Soluble Abeta oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. The Journal of neuroscience : the official journal of the Society for Neuroscience 31:6627-6638.
Li S, Murakami Y, Wang M, Maeda K, Matsumoto K (2006) The effects of chronic valproate and diazepam in a mouse model of posttraumatic stress disorder. Pharmacol Biochem Behav 85:324-331.
Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. The EMBO journal 20:27-39.
Maggio N, Segal M (2011) Persistent changes in ability to express long-term potentiation/depression in the rat hippocampus after juvenile/adult stress. Biological psychiatry 69:748-753.
Malleret G, Alarcon JM, Martel G, Takizawa S, Vronskaya S, Yin D, Chen IZ, Kandel ER, Shumyatsky GP (2010) Bidirectional regulation of hippocampal long-term synaptic plasticity and its influence on opposing forms of memory. The Journal of neuroscience : the official journal of the Society for Neuroscience 30:3813-3825.
Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M (2010) Alzheimer's disease: clinical trials and drug development. Lancet Neurol 9:702-716.
Mao L, Wang JQ (2001a) Gliogenesis in the striatum of the adult rat: alteration in neural progenitor population after psychostimulant exposure. Brain research Developmental brain research 130:41-51.
Mao L, Wang JQ (2001b) Upregulation of preprodynorphin and preproenkephalin mRNA expression by selective activation of group I metabotropic glutamate receptors in characterized primary cultures of rat striatal neurons. Brain research Molecular brain research 86:125-137.
Massey PV, Johnson BE, Moult PR, Auberson YP, Brown MW, Molnar E, Collingridge GL, Bashir ZI (2004) Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J Neurosci 24:7821-7828.
May MJ, Ghosh S (1998) Signal transduction through NF-kappa B. Immunol Today 19:80-88.
Mecocci P, Bladstrom A, Stender K (2009) Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies. Int J Geriatr Psychiatry 24:532-538.
Meda L, Cassatella MA, Szendrei GI, Otvos L, Jr., Baron P, Villalba M, Ferrari D, Rossi F (1995) Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374:647-650.
Medeiros R, Prediger RD, Passos GF, Pandolfo P, Duarte FS, Franco JL, Dafre AL, Di Giunta G, Figueiredo CP, Takahashi RN, Campos MM, Calixto JB (2007) Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein. The Journal of neuroscience : the official journal of the Society for Neuroscience 27:5394-5404.
Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, Koenigsknecht-Talboo J, Holtzman DM, Bacskai BJ, Hyman BT (2008) Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 451:720-724.
Miller TW, Isenberg JS, Roberts DD (2009) Molecular regulation of tumor angiogenesis and perfusion via redox signaling. Chem Rev 109:3099-3124.
Mouton-Liger F, Paquet C, Dumurgier J, Bouras C, Pradier L, Gray F, Hugon J (2012) Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2alpha pathway. Biochim Biophys Acta 1822:885-896.
Murakami T, Hino SI, Saito A, Imaizumi K (2007) Endoplasmic reticulum stress response in dendrites of cultured primary neurons. Neuroscience 146:1-8.
Nicholls RE, Alarcon JM, Malleret G, Carroll RC, Grody M, Vronskaya S, Kandel ER (2008) Transgenic mice lacking NMDAR-dependent LTD exhibit deficits in behavioral flexibility. Neuron 58:104-117.
Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, Dickson D, Duff K (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proceedings of the National Academy of Sciences of the United States of America 102:6990-6995.
Nyakas C, Granic I, Halmy LG, Banerjee P, Luiten PG (2011) The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-beta42 with memantine. Behavioural brain research 221:594-603.
O'Connor T, Sadleir KR, Maus E, Velliquette RA, Zhao J, Cole SL, Eimer WA, Hitt B, Bembinster LA, Lammich S, Lichtenthaler SF, Hebert SS, De Strooper B, Haass C, Bennett DA, Vassar R (2008) Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 60:988-1009.
Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM (2004) Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43:321-332.
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409-421.
Phiel CJ, Wilson CA, Lee VM, Klein PS (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423:435-439.
Pietropaolo S, Sun Y, Li R, Brana C, Feldon J, Yee BK (2009) Limited impact of social isolation on Alzheimer-like symptoms in a triple transgenic mouse model. Behav Neurosci 123:181-195.
Placido AI, Pereira CM, Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, Oliveira CR, Moreira PI (2014) The role of endoplasmic reticulum in amyloid precursor protein processing and trafficking: Implication's for Alzheimer's disease. Biochim Biophys Acta.
Rezvani AH (2006) Involvement of the NMDA System in Learning and Memory.
Rodriguez Martin T, Calella AM, Silva S, Munna E, Modena P, Chiesa R, Terrevazzi S, Ruggieri RM, Palermo R, Piccoli F, Confalonieri R, Tiraboschi P, Fragiacomo C, Quadri P, Lucca U, Forloni G (2000) Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia. Dementia and geriatric cognitive disorders 11:239-244.
Rojo LE, Fernandez JA, Maccioni AA, Jimenez JM, Maccioni RB (2008) Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch Med Res 39:1-16.
Rothman SM, Herdener N, Camandola S, Texel SJ, Mughal MR, Cong WN, Martin B, Mattson MP (2012) 3xTgAD mice exhibit altered behavior and elevated Abeta after chronic mild social stress. Neurobiology of aging 33:830 e831-812.
Ryan KA, Pimplikar SW (2005) Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J Cell Biol 171:327-335.
Salminen A, Kauppinen A, Suuronen T, Kaarniranta K, Ojala J (2009) ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology. Journal of neuroinflammation 6:41.
Schroder M, Kaufman RJ (2005) The mammalian unfolded protein response. Annual review of biochemistry 74:739-789.
Solito E, Sastre M (2012) Microglia function in Alzheimer's disease. Frontiers in pharmacology 3:14.
Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, Bruynseels K, Lasrado R, Vandezande K, Laenen I, Boon T, Van Lint J, Vandenheede J, Moechars D, Loos R, Van Leuven F (2000) Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. The Journal of biological chemistry 275:41340-41349.
Stepanichev MY, Zdobnova IM, Zarubenko, II, Moiseeva YV, Lazareva NA, Onufriev MV, Gulyaeva NV (2004) Amyloid-beta(25-35)-induced memory impairments correlate with cell loss in rat hippocampus. Physiol Behav 80:647-655.
Tai HC, Serrano-Pozo A, Hashimoto T, Frosch MP, Spires-Jones TL, Hyman BT (2012) The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. The American journal of pathology 181:1426-1435.
Takashima A, Murayama M, Murayama O, Kohno T, Honda T, Yasutake K, Nihonmatsu N, Mercken M, Yamaguchi H, Sugihara S, Wolozin B (1998) Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proceedings of the National Academy of Sciences of the United States of America 95:9637-9641.
Tan CC, Yu JT, Wang HF, Tan MS, Meng XF, Wang C, Jiang T, Zhu XC, Tan L (2014) Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis. Journal of Alzheimer's disease : JAD.
Tishkina A, Rukhlenko A, Stepanichev M, Levshina I, Pasikova N, Onufriev M, Moiseeva Y, Piskunov A, Gulyaeva N (2012) Region-specific changes in activities of cell death-related proteases and nitric oxide metabolism in rat brain in a chronic unpredictable stress model. Metabolic brain disease 27:431-441.
Torres-Lista V, Gimenez-Llort L (2013) Impairment of nesting behaviour in 3xTg-AD mice. Behav Brain Res 247:153-157.
Wang R (2002) Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB journal : official publication of the Federation of American Societies for Experimental Biology 16:1792-1798.
Wang R (2003) The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 5:493-501.
Wang Y, Che Y, Miao JT, Li ZY, Wang ZJ (2003) [The study of primary culture methods for hippocampal neurons of newborn rats]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 19:197-199.
Ward SM, Himmelstein DS, Lancia JK, Binder LI (2012) Tau oligomers and tau toxicity in neurodegenerative disease. Biochemical Society transactions 40:667-671.
Winblad B (2009) Donepezil in severe Alzheimer's disease. Am J Alzheimers Dis Other Demen 24:185-192.
Winblad B, Kilander L, Eriksson S, Minthon L, Batsman S, Wetterholm AL, Jansson-Blixt C, Haglund A (2006) Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. Lancet 367:1057-1065.
Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12:1005-1015.
Xuan A, Long D, Li J, Ji W, Zhang M, Hong L, Liu J (2012) Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer's disease. Journal of neuroinflammation 9:202.
Zauner C, Schneeweiss B, Kranz A, Madl C, Ratheiser K, Kramer L, Roth E, Schneider B, Lenz K (2000) Resting energy expenditure in short-term starvation is increased as a result of an increase in serum norepinephrine. The American journal of clinical nutrition 71:1511-1515.
Zhu L, Chen X, He X, Qi Y, Yan Y (2014) [Effect of exogenous hydrogen sulfide on BACE-1 enzyme expression and beta-amyloid peptide metabolism in high-glucose primary neuronal culture]. Nan Fang Yi Ke Da Xue Xue Bao 34:504-506, 510.